首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Thrombolytic effect of a plasminogen-plasminogen activator chimera in a photochemically induced thrombosis (PIT) model.
【2h】

Thrombolytic effect of a plasminogen-plasminogen activator chimera in a photochemically induced thrombosis (PIT) model.

机译:纤溶酶原-纤溶酶原激活物嵌合体在光化学诱导的血栓形成(PIT)模型中的溶栓作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The thrombolytic effects of the plasminogen/plasminogen activator chimera (SUN9216), comprising the fibrin-binding kringle 1 domain of plasminogen and two kringle and the serine protease domain of the wild-type tissue plasminogen activator (t-PA) including a modification of the mannose glycosylation on the kringle 1 of t-PA (PK1 delta FE1X), was compared with tht of t-PA by use of a photochemically induced thrombus (PIT) in the rat femoral artery. When SUN9216 was administered either as an i.v. infusion (1.0 mg kg-1) or as a single bolus i.v. injection (1.0 mg kg-1), all parameters were markedly improved compared to t-PA administered as an i.v. infusion (3.0 mg kg-1). A higher concentration of plasminogen activator (PA) activity in plasma was observed after administration of SUN9216 which persisted for longer than that after t-PA. It is concluded that the thrombolytic effect of SUN9216 is markedly greater than that of t-PA.
机译:纤溶酶原/纤溶酶原激活物嵌合体(SUN9216)的溶栓作用,包括纤溶酶原的纤溶蛋白结合的kringle 1结构域和两个kringle和野生型组织纤溶酶原激活物(t-PA)的丝氨酸蛋白酶结构域,包括通过在大鼠股动脉中使用光化学诱导的血栓(PIT),将t-PA的kringle 1上的甘露糖糖基化(PK1 delta FE1X)与t-PA的tht进行了比较。当SUN9216作为静脉注射给药时输注(1.0 mg kg-1)或单次静脉推注注射(1.0mg kg-1),与静脉内施用t-PA相比,所有参数均得到显着改善。输液(3.0 mg kg-1)。给予SUN9216后,血浆中的纤溶酶原激活物(PA)活性浓度更高,持续时间长于t-PA后。结论是,SUN9216的溶栓作用明显大于t-PA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号